Isotope Research Lab, Biological Engineering and Application Biology Department, Sichuan Agricultural University, Ya'an 625014, China.
Int J Mol Sci. 2023 Jan 24;24(3):2308. doi: 10.3390/ijms24032308.
Dysfunctions of the ovaries and adrenal glands are both evidenced to cause aberrant adipose tissue (AT) remodeling and resultant metabolic disorders, but their distinct and common roles are poorly understood. In this study, through biochemical, histological and RNA-seq analyses, we comprehensively explored the mechanisms underpinning subcutaneous (SAT) and visceral adipose tissue (VAT) remodeling, in response to ovariectomy (OVX) versus adrenalectomy (ADX) in female mice. OVX promoted adipocyte differentiation and fat accumulation in both SAT and VAT, by potentiating the signaling, while ADX universally prevented the cell proliferation and extracellular matrix organization in both SAT and VAT, likely by inactivating the signaling, thus causing lipoatrophy in females. ADX, but not OVX, exerted great effects on the intrinsic difference between SAT and VAT. Specifically, ADX reversed a large cluster of genes differentially expressed between SAT and VAT, by activating 12 key transcription factors, and thereby caused senescent cell accumulation, massive B cell infiltration and the development of selective inflammatory response in SAT. Commonly, both OVX and ADX enhance circadian rhythmicity in VAT, and impair cell proliferation, neurogenesis, tissue morphogenesis, as well as extracellular matrix organization in SAT, thus causing dysfunction of adipose tissues and concomitant metabolic disorders.
卵巢和肾上腺功能障碍都被证明会导致异常脂肪组织(AT)重塑和由此产生的代谢紊乱,但它们的独特和共同作用仍知之甚少。在这项研究中,我们通过生化、组织学和 RNA-seq 分析,全面探讨了卵巢切除术(OVX)和肾上腺切除术(ADX)对雌性小鼠皮下(SAT)和内脏脂肪组织(VAT)重塑的潜在机制。OVX 通过增强信号,促进 SAT 和 VAT 中脂肪细胞的分化和脂肪堆积,而 ADX 通过抑制信号普遍阻止 SAT 和 VAT 中的细胞增殖和细胞外基质组织,从而导致女性脂肪减少。ADX 而不是 OVX,对 SAT 和 VAT 之间的内在差异有很大的影响。具体而言,ADX 通过激活 12 个关键转录因子,逆转 SAT 和 VAT 之间差异表达的一大簇基因,从而导致 SAT 中衰老细胞积累、大量 B 细胞浸润和选择性炎症反应的发生。通常,OVX 和 ADX 都会增强 VAT 中的昼夜节律,并损害 SAT 中的细胞增殖、神经发生、组织形态发生以及细胞外基质组织,从而导致脂肪组织功能障碍和伴随的代谢紊乱。